Peide Bai
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Kidney Stones and Urolithiasis Treatments 8
- Prostate Cancer Diagnosis and Treatment 5
- Prostate Cancer Treatment and Research 5
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Qiang Ding (8 shared papers)Hua Xu (6 shared papers)Xuegang Wang (8 shared papers)Haowen Jiang (4 shared papers)Rongfu Liu (5 shared papers)Zhun Wu (5 shared papers)Tao Wang (13 shared papers)Yuedong Chen (3 shared papers)
- Journals
- PLoS ONE (2 papers)Cancer Biology & Therapy (2 papers)Journal of Cancer (2 papers)Journal of Cellular Biochemistry (1 paper)Renal Failure (1 paper)
- Partner nations
- China
In The Last Decade
Peide Bai
27 papers receiving 494 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 237
- Pulmonary and Respiratory Medicine 151
- Molecular Biology 265
- Oncology 104
- Urology 16
Countries citing papers authored by Peide Bai
This map shows the geographic impact of Peide Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peide Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peide Bai more than expected).
Fields of papers citing papers by Peide Bai
This network shows the impact of papers produced by Peide Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peide Bai. The network helps show where Peide Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Peide Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 82 | |
| 2 | 2018 | 75 | |
| 3 | 2014 | 46 | |
| 4 | 2014 | 40 | |
| 5 | 2015 | 37 | |
| 6 | 2018 | 35 | |
| 7 | 2019 | 26 | |
| 8 | 2017 | 24 | |
| 9 | 2015 | 18 | |
| 10 | 2018 | 16 | |
| 11 | 2014 | 12 | |
| 12 | 2015 | 12 | |
| 13 | 2019 | 11 | |
| 14 | 2018 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2024 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 6 | |
| 20 | 2023 | 5 |
About Peide Bai
Peide Bai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Pediatrics, Perinatology and Child Health, Cancer Research and Oncology, having authored 31 papers that have together received 499 indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (8 papers), Pediatric Urology and Nephrology Studies (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (4 papers), MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (237 citations), Pulmonary and Respiratory Medicine (151 citations), Molecular Biology (265 citations), Oncology (104 citations) and Urology (16 citations). Peide Bai has collaborated with scholars based in China. Frequent co-authors include Qiang Ding, Hua Xu, Xuegang Wang, Haowen Jiang, Rongfu Liu, Zhun Wu, Tao Wang, Yuedong Chen, Jinchun Xing and Mengbo Hu. Their work appears in journals such as PLoS ONE, Cancer Biology & Therapy, Journal of Cancer, Journal of Cellular Biochemistry and Renal Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.